The "Cardiac Rhythm Management Devices - Global Market Outlook (2018-2027)" report has been added to ResearchAndMarkets.com's offering.
The Global Cardiac Rhythm Management Devices Market accounted for $20.32 billion in 2018 and is expected to reach $42.78 billion by 2027 growing at a CAGR of 8.6% during the forecast period.
Increasing awareness regarding cardiac disorders, rising demand for implantable cardioverter-defibrillator devices in developing economies and growing geriatric population base coupled with the rising prevalence of obesity are some of the factors fuelling the market growth. However, High cost of devices and Complications of CRT in children is restricting the market growth.
Cardiac rhythm management is a treatment of arrhythmias (heart rhythm disorders) or atrial fibrillation (AF). Arrhythmia causes palpitations and dizzy spells to sudden cardiac arrest. Cardiac rhythm management devices include pacemakers, cardiac resynchronization therapy devices, and implantable cardiac defibrillators.
Based on the product, the cardiac resynchronization therapy (CRT) segment is anticipated to register lucrative growth over the forecast period. The growth of CRT devices is majorly due to the rising prevalence of heart failure witnessed across the globe. Moreover, Growing number of geriatric population across the globe along with the rising incidence of atrial fibrillation, arrhythmias, congenital heart diseases are some other factors that have augmented the need and demand for resynchronization therapy devices products.
By Geography, North America is expected to have a significant market growth during the forecast period, owing to increasing incidence rate of cardiovascular diseases across various countries in the region, increasing elderly population, ready acceptance of technological advanced products (long battery life, biocompatible materials or miniaturization, & leadless) and increasing regulatory approvals.
What the report offers:
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2017, 2018, 2019, 2023 and 2027
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic analysis: Drivers and Constraints, Product/Technology Analysis, Porter's five forces analysis, SWOT analysis, etc.
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements
Key Topics Covered:
1 Executive Summary
2 Preface
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions
3 Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Product Analysis
3.7 Application Analysis
3.8 End User Analysis
3.9 Emerging Markets
3.10 Futuristic Market Scenario
4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry
5 Global Cardiac Rhythm Management Devices Market, By Product
5.1 Introduction
5.2 Defibrillator
5.2.1 External Defibrillator (ED)
5.2.1.1 Automated External Defibrillators (AEDs)
5.2.1.1.1 Fully Automated External Defibrillator
5.2.1.1.2 Semi-automated External Defibrillator
5.2.1.2 Manual External Defibrillators
5.2.1.3 Wearable Cardioverter Defibrillator
5.2.2 Implantable Cardioverter Defibrillators (ICDs)
5.2.2.1 Transvenous ICD (T-ICD)
5.2.2.1.1 Dual-chamber ICDs
5.2.2.1.2 Biventricular ICDs
5.2.2.1.3 Single-chamber ICDs
5.2.2.2 Subcutaneous ICD (S-ICD)
5.3 Cardiac Resynchronization Therapy (CRT)
5.3.1 CRT-Defibrillators (CRT-Ds)
5.3.2 CRT-Pacemakers (CRT-Ps)
5.4 Pacemakers
5.4.1 Single Chamber Cardiac Pacemaker
5.4.2 Bi Ventricular Pacemakers
5.4.3 Dual Chamber Cardiac Pacemaker
5.4.4 Leadless Pacemaker
5.4.5 Implantability
5.4.5.1 Implantable Pacemakers
5.4.5.2 External Pacemakers
5.4.6 Traditional Pacemaker
5.5 Accessories
5.5.1 Defibrillation Leads
5.5.2 Pacing Leads
5.6 Other Products
6 Global Cardiac Rhythm Management Devices Market, By Application
6.1 Introduction
6.2 Bradycardia
6.3 Heart Failure
6.4 Tachycardia
6.5 Other Applications
7 Global Cardiac Rhythm Management Devices Market, By End User
7.1 Introduction
7.2 Hospitals & Clinics
7.3 Home Care Settings
7.4 Ambulatory Surgery Centers
7.5 Cardiac Centers
7.6 Other End Users
8 Global Cardiac Rhythm Management Devices Market, By Geography
8.1 Introduction
8.2 North America
8.3 Europe
8.4 Asia Pacific
8.5 South America
8.6 Middle East & Africa
9 Key Developments
9.1 Agreements, Partnerships, Collaborations and Joint Ventures
9.2 Acquisitions & Mergers
9.3 New Product Launch
9.4 Expansions
9.5 Other Key Strategies
10 Company Profiling
10.1 Abiomed, Inc.
10.2 Defibtech, LLC.
10.3 Boston Scientific Corporation
10.4 SCHILLER AG
10.5 Stryker
10.6 Koninklijke Philips N.V.
10.7 Medtronic plc
10.8 General Electric (GE) Company
10.9 LivaNova PLC
10.10 Cardiac Science Corporation
10.11 Hill-Rom Holdings, Inc.
10.12 Biotronik SE & Co. KG
10.13 Berlin Heart GmbH
10.14 Abbott Laboratories
10.15 St. Jude Medical
10.16 Altera
For more information about this report visit https://www.researchandmarkets.com/r/yjxrcv
View source version on businesswire.com: https://www.businesswire.com/news/home/20200120005335/en/
Contacts:
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
